chronically
reserpinized
rat
possible
model
cystic
fibrosis
vi
synergistic
effect
isoproterenol
ca
protein
submaxillary
gland
elevated
calcium
protein
concentration
consistent
abnormality
submaxillary
saliva
patient
cystic
fibrosis
cf
experimental
animal
model
developed
chronic
administration
either
isoproterenol
ipr
reserpine
possibility
effect
two
drug
may
additive
investigated
assessing
combined
effect
glandular
salivary
c
protein
rat
submaxillary
gland
individually
effect
also
assessed
relation
dose
used
result
indicate
treatment
day
mg
kg
daily
dose
reserpine
caused
respectively
increase
glandular
ca
increase
glandular
protein
treatment
day
mg
kg
daily
dose
isoproterenol
caused
increase
gland
ca
increase
gland
protein
treatment
mg
rat
daily
dose
drug
caused
increase
gland
ca
protein
experiment
involving
combination
two
drug
isoproterenol
administered
mg
kg
daily
dose
day
reserpine
mg
kg
daily
dose
day
treatment
schedule
procedure
resulted
increase
gland
ca
increase
gland
protein
b
marked
accumulation
granular
basophilic
material
acinar
cell
development
intraductal
precipitate
c
secretion
turbid
saliva
high
ca
protein
concentration
secretory
dose
isoproterenol
type
stimulation
also
reduced
gland
ca
protein
content
produced
vacuolization
acinar
cell
secretion
saliva
elevated
ca
protein
response
pilocarpine
elevated
concentration
however
one
fifth
obtained
isoproterenol
stimulation
e
secretion
smaller
volume
saliva
type
stimulation
finding
indicate
ipr
reserpine
dose
related
significant
effect
submaxillary
gland
ca
protein
individual
effect
synergistic
implication
synergism
physiologic
state
submaxillary
gland
secretory
abnormality
cystic
fibrosis
discussed
